We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
-11.97%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$10.6B
AUM Growth
-$1.52B
Cap. Flow
+$47.1M
Cap. Flow %
0.44%
Top 10 Hldgs %
18.51%
Holding
395
New
8
Increased
194
Reduced
112
Closed
28

Top Buys

Rank Stock Value
1
CLB icon
Core Laboratories
CLB
+$53M
2
AZPN
Aspen Technology Inc
AZPN
+$36M
3
COLD icon
Americold
COLD
+$32.5M
4
A icon
Agilent Technologies
A
+$31M
5
TFX icon
Teleflex
TFX
+$20.6M

Top Sells

Rank Stock Value
1
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$66.2M
2
MTB icon
M&T Bank
MTB
+$43.8M
3
BKR icon
Baker Hughes
BKR
+$38.3M
4
ORCL icon
Oracle
ORCL
+$36.5M
5
CDK
CDK Global, Inc.
CDK
+$35.6M

Sector Composition

Rank Sector Weight
1 Technology 19.35%
2 Healthcare 17.05%
3 Financials 15.67%
4 Industrials 13.84%
5 Consumer Discretionary 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZN icon
326
AstraZeneca
AZN
$269B
$357K ﹤0.01%
2,700
– –
DUK icon
327
Duke Energy
DUK
$101B
$352K ﹤0.01%
3,283
-566
-15% -$62.2K
OTIS icon
328
Otis Worldwide
OTIS
$27.9B
$341K ﹤0.01%
4,829
-999
-17% -$73.6K
SCHW
329
Charles Schwab
SCHW
$182B
$335K ﹤0.01%
5,305
+35
+0.7% +$2.41K
MCHP icon
330
Microchip Technology
MCHP
$38.8B
$319K ﹤0.01%
5,500
– –
VRTX icon
331
Vertex Pharmaceuticals
VRTX
$123B
$313K ﹤0.01%
1,110
-90
-8% -$24.1K
BRKL
332
DELISTED
Brookline Bancorp
BRKL
$286K ﹤0.01%
21,500
– –
CSL icon
333
Carlisle Companies
CSL
$13.5B
$286K ﹤0.01%
1,200
– –
GNTX icon
334
Gentex
GNTX
$5.1B
$282K ﹤0.01%
10,072
– –
IJR icon
335
iShares Core S&P Small-Cap ETF
IJR
$109B
$280K ﹤0.01%
3,033
– –
ROP icon
336
Roper Technologies
ROP
$40.4B
$279K ﹤0.01%
706
-185
-21% -$80.4K
WM icon
337
Waste Management
WM
$95B
$269K ﹤0.01%
1,759
+16
+0.9% +$2.51K
DORM icon
338
Dorman Products
DORM
$4.22B
$268K ﹤0.01%
2,440
– –
WAB icon
339
Wabtec
WAB
$49.3B
$267K ﹤0.01%
3,251
-2
-0.1% -$178
NICE icon
340
Nice
NICE
$6.15B
$266K ﹤0.01%
1,380
– –
AMT icon
341
American Tower
AMT
$83.5B
$264K ﹤0.01%
1,032
+100
+11% +$25.1K
K
342
DELISTED
Kellanova
K
$264K ﹤0.01%
3,941
-1,065
-21% -$69.2K
VNQ icon
343
Vanguard Real Estate ETF
VNQ
$39.9B
$262K ﹤0.01%
2,881
– –
XYL icon
344
Xylem
XYL
$28.5B
$259K ﹤0.01%
3,311
– –
BEN icon
345
Franklin Resources
BEN
$16.8B
$256K ﹤0.01%
11,000
– –
NOW icon
346
ServiceNow
NOW
$120B
$253K ﹤0.01%
+2,655
New +$253K
NVDA icon
347
NVIDIA
NVDA
$4.6T
$249K ﹤0.01%
16,450
+4,050
+33% +$76.4K
IJH icon
348
iShares Core S&P Mid-Cap ETF
IJH
$121B
$248K ﹤0.01%
5,490
– –
PLD icon
349
Prologis
PLD
$136B
$244K ﹤0.01%
+2,074
New +$287K
PPLI
350
People Inc
PPLI
$3.12B
$239K ﹤0.01%
3,828
– –
12 13
14
15 16

Similar funds

TWIM
TIAA Wealth Investment Management New York $13.1B AUM
PFPG
Pinnacle Financial Partners (Georgia) Atlanta, Georgia $13.1B AUM
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
EPFB
Employees Provident Fund Board Shah Alam, Malaysia $13.2B AUM 29.65% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $13B AUM 17.65% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
MGIA
Moneta Group Investment Advisors St Louis, Missouri $13.3B AUM 18.65% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

Boston Trust Walden's Q2 2022 Portfolio in Review

As of Q2 2022, Boston Trust Walden held 395 positions worth $10.6B, down 13% from $12.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Boston Trust Walden's Q2 2022 filing shows 8 new, 194 increased, 112 reduced and 28 closed positions. Its largest new stake was Core Laboratories: 1,993,528 shares worth $39.5M. The largest sale was ASPEN TECHNOLOGY INC, an estimated $66.2M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Boston Trust Walden's largest Q2 2022 buy was Core Laboratories: 1,993,528 shares worth $39.5M.
  • Boston Trust Walden added most to Americold in Q2 2022, an estimated $32.5M increase.
  • Boston Trust Walden's biggest Q2 2022 reduction was M&T Bank, cutting an estimated $43.8M.
  • Boston Trust Walden fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $66.2M.
  • Boston Trust Walden's ten largest holdings make up 19% of its $10.6B portfolio in Q2 2022.
  • Boston Trust Walden opened 8 new positions and closed 28 in Q2 2022.
  • Boston Trust Walden's portfolio value fell 13% quarter-over-quarter to $10.6B.

Based on Boston Trust Walden's 13F filing for Q2 2022, filed 22 Jul 2022.